Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
ENSIGN GROUP, INC (ENSG)
Shaw Daren — Director
Shares
1,000
Price
$213.43
Total Value
$213.43K
Shares Held After
23,726
% of Holdings
4.0%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
378
Price
$8.63
Total Value
$3.26K
Shares Held After
99,429
% of Holdings
0.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
1,557
Price
$489.46
Total Value
$762.09K
Shares Held After
8,388
% of Holdings
15.7%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
3,541
Price
$53.11
Total Value
$188.06K
Shares Held After
287,788
% of Holdings
1.2%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
26,952
Price
$52.69
Total Value
$1.42M
Shares Held After
291,329
% of Holdings
8.5%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
16,616
Price
$51.42
Total Value
$854.44K
Shares Held After
318,281
% of Holdings
5.0%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
21,858
Price
$50.32
Total Value
$1.10M
Shares Held After
334,897
% of Holdings
6.1%
Twist Bioscience Corp (TWST)
Green Paula — SVP of Human Resources
Shares
39,404
Price
$52.40
Total Value
$2.06M
Shares Held After
126,041
% of Holdings
23.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
2,031
Price
$489.46
Total Value
$994.09K
Shares Held After
21,544
% of Holdings
8.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
2,476
Price
$489.46
Total Value
$1.21M
Shares Held After
16,992
% of Holdings
12.7%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
4,321
Price
$28.26
Total Value
$122.12K
Shares Held After
105,211
% of Holdings
3.9%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
5,679
Price
$27.50
Total Value
$156.20K
Shares Held After
109,532
% of Holdings
4.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
2,437
Price
$489.46
Total Value
$1.19M
Shares Held After
9,668
% of Holdings
20.1%
Ceribell, Inc. (CBLL)
Parvizi Josef — Director
Shares
1,300
Price
$20.00
Total Value
$26.00K
Shares Held After
746,352
% of Holdings
0.2%
JOHNSON & JOHNSON (JNJ)
Broadhurst Vanessa — EVP, Global Corp Affairs
Shares
6,197
Price
$243.39
Total Value
$1.51M
Shares Held After
23,003
% of Holdings
21.2%
JOHNSON & JOHNSON (JNJ)
REED JOHN C — EVP, Innovative Medicine, R&D
Shares
2,283
Price
$243.00
Total Value
$554.77K
Shares Held After
10,658
% of Holdings
17.6%
JOHNSON & JOHNSON (JNJ)
REED JOHN C — EVP, Innovative Medicine, R&D
Shares
29,927
Price
$243.00
Total Value
$7.27M
Shares Held After
12,941
% of Holdings
69.8%
JOHNSON & JOHNSON (JNJ)
REED JOHN C — EVP, Innovative Medicine, R&D
Shares
21,721
Price
$243.00
Total Value
$5.28M
Shares Held After
12,941
% of Holdings
62.7%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
24,961
Price
$242.68
Total Value
$6.06M
Shares Held After
14,000
% of Holdings
64.1%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
33,386
Price
$242.75
Total Value
$8.10M
Shares Held After
38,961
% of Holdings
46.1%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
12,066
Price
$242.87
Total Value
$2.93M
Shares Held After
38,961
% of Holdings
23.6%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
19,241
Price
$242.99
Total Value
$4.68M
Shares Held After
38,961
% of Holdings
33.1%
JOHNSON & JOHNSON (JNJ)
Swanson James D. — EVP, CIO
Shares
20,521
Price
$242.70
Total Value
$4.98M
Shares Held After
25,698
% of Holdings
44.4%
Adagio Therapeutics, Inc. (ADGI)
Andersen Jill — Chief Legal Officer, Secretary
Shares
32,771
Price
$1.54
Total Value
$50.45K
Shares Held After
216,675
% of Holdings
13.1%
Adagio Therapeutics, Inc. (ADGI)
Lee Timothy Edward — Chief Commercial Officer
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
138,681
% of Holdings
12.4%
Adagio Therapeutics, Inc. (ADGI)
Duke William E. — Chief Financial Officer
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
128,681
% of Holdings
13.3%
EXELIXIS, INC. (EXEL)
Haley Patrick J. — EVP, Commercial
Shares
64,778
Price
$43.50
Total Value
$2.82M
Shares Held After
381,908
% of Holdings
14.5%
EXELIXIS, INC. (EXEL)
Haley Patrick J. — EVP, Commercial
Shares
3,036
Price
$43.84
Total Value
$133.10K
Shares Held After
446,686
% of Holdings
0.7%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
30,617
Price
$43.67
Total Value
$1.34M
Shares Held After
976,092
% of Holdings
3.0%
Adagio Therapeutics, Inc. (ADGI)
Green Julie — Chief Human Resources Officer
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
128,681
% of Holdings
13.3%
Adagio Therapeutics, Inc. (ADGI)
Allen Robert D. III — Chief Scientific Officer
Shares
18,189
Price
$1.54
Total Value
$28.00K
Shares Held After
133,879
% of Holdings
12.0%
SI-BONE, Inc. (SIBN)
RECUPERO ANTHONY J — Former President, Commercial Operations
Shares
3,065
Price
$15.45
Total Value
$47.36K
Shares Held After
243,418
% of Holdings
1.2%
SI-BONE, Inc. (SIBN)
RECUPERO ANTHONY J — Former President, Commercial Operations
Shares
11,143
Price
$15.41
Total Value
$171.67K
Shares Held After
246,483
% of Holdings
4.3%
SI-BONE, Inc. (SIBN)
RECUPERO ANTHONY J — Former President, Commercial Operations
Shares
1,710
Price
$15.41
Total Value
$26.35K
Shares Held After
257,626
% of Holdings
0.7%
SI-BONE, Inc. (SIBN)
RECUPERO ANTHONY J — Former President, Commercial Operations
Shares
3,040
Price
$15.42
Total Value
$46.86K
Shares Held After
259,336
% of Holdings
1.2%
SI-BONE, Inc. (SIBN)
RECUPERO ANTHONY J — Former President, Commercial Operations
Shares
2,091
Price
$15.28
Total Value
$31.95K
Shares Held After
262,376
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
200
Price
$75.38
Total Value
$15.08K
Shares Held After
336,585
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
13,400
Price
$74.71
Total Value
$1.00M
Shares Held After
336,785
% of Holdings
3.8%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
510
Price
$74.31
Total Value
$37.90K
Shares Held After
123,945
% of Holdings
0.4%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
4,083
Price
$39.80
Total Value
$162.50K
Shares Held After
288,976
% of Holdings
1.4%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
8,159
Price
$39.22
Total Value
$319.96K
Shares Held After
293,059
% of Holdings
2.7%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
2,341
Price
$38.07
Total Value
$89.11K
Shares Held After
301,218
% of Holdings
0.8%
MCKESSON CORP (MCK)
Smith LeAnn B — EVP & Chief HR Officer
Shares
190
Price
$945.00
Total Value
$179.55K
Shares Held After
2,989
% of Holdings
6.0%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
3,891
Price
$15.41
Total Value
$59.95K
Shares Held After
266,466
% of Holdings
1.4%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
3,065
Price
$15.46
Total Value
$47.38K
Shares Held After
270,357
% of Holdings
1.1%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
2,189
Price
$15.29
Total Value
$33.47K
Shares Held After
273,422
% of Holdings
0.8%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
11,104
Price
$15.36
Total Value
$170.55K
Shares Held After
275,611
% of Holdings
3.9%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
1,279
Price
$15.35
Total Value
$19.63K
Shares Held After
286,715
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
2,033
Price
$15.30
Total Value
$31.09K
Shares Held After
544,369
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
7,888
Price
$15.44
Total Value
$121.76K
Shares Held After
546,402
% of Holdings
1.4%
Showing 701–750 of 1586 transactions (page 15 of 32)